The cathelicidins LL-37 and rCRAMP are associated with pathogenic events of arthritis in humans and rats

Annals of the Rheumatic Diseases

Volumn 72, Issue 7, 2013, Pages 1239-1248

  Hoffmann, Markus H ^a,b   Bruns, Heiko ^b   Bac̈kdahl, Liselotte ^a   Neregar̊d, Petra ^c   Niederreiter, Birgit ^d   Herrmann, Martin ^b   Catrina, Anca Irinel ^c   Agerberth, Birgitta ^a   Holmdahl, Rikard ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA DEFENSIN; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; DEFENSIN; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; L SELECTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHRITIS; ARTICLE; BLOOD SAMPLING; CD4+ T LYMPHOCYTE; CELL DEATH; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN TISSUE; LYMPHOID ORGAN; MACROPHAGE; MOLECULAR PATHOLOGY; MONOCYTE; NEUTROPHIL; NONHUMAN; OSTEOCLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SPLEEN; SYNOVIUM; UPREGULATION;

AUTOANTIBODIES; AUTOIMMUNITY; RHEUMATOID ARTHRITIS;

ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; CASE-CONTROL STUDIES; CATHELICIDINS; DEFENSINS; HUMANS; INTERFERON-ALPHA; NEUTROPHILS; OSTEOCLASTS; RATS; SYNOVIAL MEMBRANE; UP-REGULATION;

EID: 84878402295     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2012-202218     Document Type: Article

References (48)

1. Ganguly D, Chamilos G, Lande R, et al. Self-RNA-antimicrobial peptide complexes activate human dendritic cells through TLR7 and TLR8. J Exp Med 2009;206:1983-94.
2. Garcia-Romo GS, Caielli S, Vega B, et al. Netting neutrophils are major inducers of type I IFN production in pediatric systemic lupus erythematosus. Sci Transl Med 2011;3:73ra20.
3. Lande R, Ganguly D, Facchinetti V, et al. Neutrophils activate plasmacytoid dendritic cells by releasing self-DNA-peptide complexes in systemic lupus erythematosus. Sci Transl Med 2011;3:73ra19.
4. Lande R, Gregorio J, Facchinetti V, et al. Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide. Nature 2007;449:564-9. (Pubitemid 47525141)
5. Nijnik A, Hancock R. Host defence peptides: antimicrobial and immunomodulatory activity and potential applications for tackling antibiotic-resistant infections. Emerg Health Threats J 2009;2:e1.
6. De Y, Chen Q, Schmidt AP, et al. LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes and T cells. J Exp Med 2000;192:1069-74.
7. Mookherjee N, Brown KL, Bowdish DM, et al. Modulation of the TLR-mediated inflammatory response by the endogenous human host defense peptide LL-37. J Immunol 2006;176:2455-64. (Pubitemid 43201696)
8. Morizane S, Yamasaki K, Muhleisen B, et al. Cathelicidin antimicrobial peptide LL-37 in psoriasis enables keratinocyte reactivity against TLR9 ligands. J Invest Dermatol 2012;132:135-43.
9. Baechler EC, Batliwalla FM, Karypis G, et al. Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc Natl Acad Sci U S A 2003;100:2610-15. (Pubitemid 36297546)
10. Bennett L, Palucka AK, Arce E, et al. Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J Exp Med 2003;197:711-23. (Pubitemid 36350866)
11. van der Pouw Kraan TC, Wijbrandts CA, van Baarsen LG, et al. Rheumatoid arthritis subtypes identified by genomic profiling of peripheral blood cells: assignment of a type I interferon signature in a subpopulation of patients. Ann Rheum Dis 2007;66:1008-14. (Pubitemid 47122311)
12. Frohm M, Agerberth B, Ahangari G, et al . The expression of the gene coding for the antibacterial peptide LL-37 is induced in human keratinocytes during inflammatory disorders. J Biol Chem 1997;272:15258-63. (Pubitemid 27255544)
13. Sun CL, Zhang FZ, Li P, et al. LL-37 expression in the skin in systemic lupus erythematosus. Lupus 2011;20:904-11.
14. Paulsen F, Pufe T, Conradi L, et al. Antimicrobial peptides are expressed and produced in healthy and inflamed human synovial membranes. J Pathol 2002;198:369-77. (Pubitemid 35277388)
15. Matsumoto T, Kaneko T, Seto M, et al. The membrane proteinase 3 expression on neutrophils was downregulated after treatment with infliximab in patients with rheumatoid arthritis. Clin Appl Thromb Hemost 2008;14:186-92. (Pubitemid 351364011)
16. Vingsbo C, Sahlstrand P, Brun JG, et al. Pristane-induced arthritis in rats: a new model for rheumatoid arthritis with a chronic disease course influenced by both major histocompatibility complex and non-major histocompatibility complex genes. Am J Pathol 1996;149:1675-83. (Pubitemid 26363973)
17. Hoffmann MH, Tuncel J, Skriner K, et al. The rheumatoid arthritis-associated autoantigen hnRNP-A2 (RA33) is a major stimulator of autoimmunity in rats with pristane-induced arthritis. J Immunol 2007;179:7568-76.
18. Russo-Carbolante EMS, Azzolini AECS, Plizello ACM, et al. Comparative study of four isolation procedures to obtain rat neutrophils. Comp Clin Pathol 2002;11:71-6. (Pubitemid 35282773)
19. Termen S, Tollin M, Olsson B, et al. Phylogeny, processing and expression of the rat cathelicidin rCRAMP: a model for innate antimicrobial peptides. Cell Mol Life Sci 2003;60:536-49. (Pubitemid 36459532)
20. Holness CL, Simmons DL. Molecular cloning of CD68, a human macrophage marker related to lysosomal glycoproteins. Blood 1993;81:1607-13. (Pubitemid 23083842)
21. Mordue DG, Sibley LD. A novel population of Gr-1+-activated macrophages induced during acute toxoplasmosis. J Leukoc Biol 2003;74:1015-25. (Pubitemid 38040323)
22. Matsumoto H, Kumon Y, Watanabe H, et al. Antibodies to CD11b, CD68 and lectin label neutrophils rather than microglia in traumatic and ischemic brain lesions. J Neurosci Res 2007;85:994-1009. (Pubitemid 46580341)
23. Gearing AJ, Newman W. Circulating adhesion molecules in disease. Immunol Today 1993;14:506-12. (Pubitemid 23301002)
24. Calvani N, Caricchio R, Tucci M, et al. Induction of apoptosis by the hydrocarbon oil pristane: implications for pristane-induced lupus. J Immunol 2005;175:4777-82. (Pubitemid 41362020)
25. Herman S, Kny A, Schorn C, et al. Cell death and cytokine production induced by autoimmunogenic hydrocarbon oils. Autoimmunity 2012; Epub ahead of print.
26. Kleinau S, Dencker L, Klareskog L. Oil-induced arthritis in DA rats: tissue distribution of arthritogenic 14C-labelled hexadecane. Int J Immunopharmacol 1995;17:393-401.
27. Fuchs TA, Abed U, Goosmann C, et al. Novel cell death program leads to neutrophil extracellular traps. J Cell Biol 2007;176:231-41. (Pubitemid 46143263)
28. Cederlund A, Gudmundsson GH, Agerberth B. Antimicrobial peptides important in innate immunity. FEBS J 2011;278:3942-51.
29. Yount NY, Wang MS, Yuan J, et al. Rat neutrophil defensins. Precursor structures and expression during neutrophilic myelopoiesis. J Immunol 1995;155:4476-84.
30. Jia HP, Mills JN, Barahmand-Pour F, et al. Molecular cloning and characterization of rat genes encoding homologues of human beta-defensins. Infect Immun 1999;67:4827-33. (Pubitemid 29400470)
31. Eisenhauer PB, Harwig SS, Szklarek D, et al. Purification and antimicrobial properties of three defensins from rat neutrophils. Infect Immun 1989;57:2021-7. (Pubitemid 19186878)
32. Sorensen OE, Follin P, Johnsen AH, et al. Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3. Blood 2001;97:3951-9.
33. Zanetti M, Gennaro R, Romeo D. Cathelicidins: a novel protein family with a common proregion and a variable C-terminal antimicrobial domain. FEBS Lett 1995;374:1-5.
34. Turner J, Cho Y, Dinh NN, et al. Activities of LL-37, a cathelin-associated antimicrobial peptide of human neutrophils. Antimicrob Agents Chemother 1998;42:2206-14. (Pubitemid 28420351)
35. Johansson J, Gudmundsson GH, Rottenberg ME, et al. Conformation-dependent antibacterial activity of the naturally occurring human peptide LL-37. J Biol Chem 1998;273:3718-24. (Pubitemid 28109800)
36. Mohr W, Kohler G, Wessinghage D. Polymorphonuclear granulocytes in rheumatic tissue destruction. II. Demonstration of PMNs in rheumatoid nodules by electron microscopy. Rheumatol Int 1981;1:21-8. (Pubitemid 11038451)
37. Wright HL, Moots RJ, Bucknall RC, et al. Neutrophil function in inflammation and inflammatory diseases. Rheumatology (Oxford) 2010;49:1618-31.
38. Chou RC, Kim ND, Sadik CD, et al. Lipid-cytokine-chemokine cascade drives neutrophil recruitment in a murine model of inflammatory arthritis. Immunity 2010;33:266-78.
39. Holmdahl R, Jansson L, Larsson A, et al. Arthritis in DBA/1 mice induced with passively transferred type II collagen immune serum. Immunohistopathology and serum levels of anti-type II collagen auto-antibodies. Scand J Immunol 1990;31:147-57. (Pubitemid 20049601)
40. Holmdahl R, Jonsson R, Larsson P, et al. Early appearance of activated CD4+ T lymphocytes and class II antigen-expressing cells in joints of DBA/1 mice immunized with type II collagen. Lab Invest 1988;58:53-60. (Pubitemid 18042440)
41. Wipke BT, Allen PM. Essential role of neutrophils in the initiation and progression of a murine model of rheumatoid arthritis. J Immunol 2001;167:1601-8. (Pubitemid 32703161)
42. Satoh M, Reeves WH. Induction of lupus-associated autoantibodies in BALB/c mice by intraperitoneal injection of pristane. J Exp Med 1994;180:2341-6. (Pubitemid 24351616)
43. Wooley PH, Seibold JR, Whalen JD, et al. Pristane-induced arthritis. The immunologic and genetic features of an experimental murine model of autoimmune disease. Arthritis Rheum 1989;32:1022-30. (Pubitemid 19218382)
44. Dahlgren J, Takhar H, Anderson-Mahoney P. Cluster of systemic lupus erythematosus (SLE) associated with an oil field waste site: a cross sectional study. Environ Health 2007;6:8.
45. Sverdrup B, Kallberg H, Bengtsson C, et al. Association between occupational exposure to mineral oil and rheumatoid arthritis: results from the Swedish EIRA case-control study. Arthritis Res Ther 2005;7:R1296-303.
46. Holmberg J, Tuncel J, Yamada H, et al. Pristane, a non-antigenic adjuvant, induces MHC class II-restricted, arthritogenic T cells in the rat. J Immunol 2006;176:1172-9. (Pubitemid 43099720)
47. Doreau A, Belot A, Bastid J, et al. Interleukin 17 acts in synergy with B cell-activating factor to influence B cell biology and the pathophysiology of systemic lupus erythematosus. Nat Immunol 2009;10:778-85.
48. Lit LC, Wong CK, Tam LS, et al. Raised plasma concentration and ex vivo production of inflammatory chemokines in patients with systemic lupus erythematosus. Ann Rheum Dis 2006;65:209-15. (Pubitemid 43131995)